연구성과로 돌아가기

2024 연구성과별 연구자 정보 (1480 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Multi-omic Profiling Identifies Pathogenic Pro-inflammatory Human Monocytes/Macrophages in Systemic Lupus Erythematosus Kang, Insoo Kang, I 29 Yale Univ, Internal Med Rheumatol Allergy & Immunol, Sch Med, New Haven, CT USA
Multi-Sensor Photoelectric Fire Alarm Device Implementation for Early Fire Detection in Campsites Choi, Wonjun Choi, W 1 Kyungpook Natl Univ, Sch Elect Engn, Daegu 41566, South Korea 7373wj@naver.com;iyjung@ee.knu.ac.kr;
Multi-Sensor Photoelectric Fire Alarm Device Implementation for Early Fire Detection in Campsites Jung, Im Y. Jung, IY 2 교신저자 Kyungpook Natl Univ, Sch Elect & Elect Engn, Daegu 41566, South Korea 0000-0002-9713-1757 Jung, Im 7373wj@naver.com;iyjung@ee.knu.ac.kr;
Multi-Task Learning With Self-Defined Tasks for Adversarial Robustness of Deep Networks Hyun, Changhun Hyun, C 1 Kyungpook Natl Univ, Sch Comp Sci & Engn, Daegu 41566, South Korea MYR-4076-2025 HYUN, CHANGHUN 0000-0002-6984-2375 Hyun, Changhun hypark@knu.ac.kr;
Multi-Task Learning With Self-Defined Tasks for Adversarial Robustness of Deep Networks Park, Hyeyoung Park, H 2 교신저자 Kyungpook Natl Univ, Sch Comp Sci & Engn, Daegu 41566, South Korea hypark@knu.ac.kr;
Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse Al-Shaibani, Eshrak Al-Shaibani, E 1 Princess Margaret Hosp, Hans Messner Allogene Transplant Program, Div Med Oncol & Hematol, Toronto, ON, Canada
Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse Cai, Yu Cai, Y 2 Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Shanghai, Peoples R China
Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse Song, Xianmin Song, XM 3 Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Shanghai, Peoples R China
Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse Al Zahrani, Mohsen Al Zahrani, M 4 Minist Natl Guard Hlth Affairs, King Abdulaziz Med City, Riyadh, Saudi Arabia
Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse Elemary, Mohamed Elemary, M 5 Univ Saskatchewan, Prov Hematol & Blood & Marrow Transplant Program, Saskatchewan Canc Agcy, Saskatoon, SK, Canada
Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse Alhumaid, Muhned Alhumaid, M 6 King Fahad Med City, Dept Hematol, Riyadh, Saudi Arabia AHA-2993-2022 Alhumaid, Muhned
Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse Alkhaldi, Hanan Alkhaldi, H 7 KFSHRC, Stem Cell Transplantat & Cellular Therapy, Dept Hematol, Riyadh, Saudi Arabia
Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse Saad, Ayman Saad, A 8 KFSHRC, Stem Cell Transplantat & Cellular Therapy, Dept Hematol, Riyadh, Saudi Arabia
Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse Bbiavasco, Francesc Bbiavasco, F 9 Univ Freiburg, Med Ctr, Dept Med 1, Freiburg, Germany
Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse Zeiser, Robert Zeiser, R 10 Univ Freiburg, Med Ctr, Dept Med 1, Freiburg, Germany AEF-7995-2022 Zeiser, Robert
페이지 이동: